
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy
Yanhua Li, Xia Zhang, Xiaohan Liu, et al.
Chemical Science (2021) Vol. 12, Iss. 9, pp. 3130-3145
Open Access | Times Cited: 34
Yanhua Li, Xia Zhang, Xiaohan Liu, et al.
Chemical Science (2021) Vol. 12, Iss. 9, pp. 3130-3145
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 280
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 280
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 195
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 195
Evolution of nanomedicine formulations for targeted delivery and controlled release
Sanyogitta Puri, Mariarosa Mazza, Gourgopal Roy, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114962-114962
Closed Access | Times Cited: 47
Sanyogitta Puri, Mariarosa Mazza, Gourgopal Roy, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114962-114962
Closed Access | Times Cited: 47
Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy
Yijing Zhang, Jing Li, Kanyi Pu
Biomaterials (2022) Vol. 291, pp. 121906-121906
Closed Access | Times Cited: 48
Yijing Zhang, Jing Li, Kanyi Pu
Biomaterials (2022) Vol. 291, pp. 121906-121906
Closed Access | Times Cited: 48
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment
Jun Zheng, Ju Huang, Liang Zhang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Jun Zheng, Ju Huang, Liang Zhang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death
Asmita Banstola, Kishwor Poudel, Jong Oh Kim, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 505-520
Closed Access | Times Cited: 52
Asmita Banstola, Kishwor Poudel, Jong Oh Kim, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 505-520
Closed Access | Times Cited: 52
Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy
Tingting Hu, Chao Shen, Xueyan Wang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 11, pp. 109562-109562
Closed Access | Times Cited: 8
Tingting Hu, Chao Shen, Xueyan Wang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 11, pp. 109562-109562
Closed Access | Times Cited: 8
Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release
Adila Nazli, Muhammad Zafar Irshad Khan, Ákos Rácz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116699-116699
Open Access | Times Cited: 6
Adila Nazli, Muhammad Zafar Irshad Khan, Ákos Rácz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116699-116699
Open Access | Times Cited: 6
Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy
Shu‐Cheng Wan, Meng‐Jie Ye, Qi‐Chao Yang, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 7
Closed Access | Times Cited: 26
Shu‐Cheng Wan, Meng‐Jie Ye, Qi‐Chao Yang, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 7
Closed Access | Times Cited: 26
Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy
Susanta Kumar Rout, Vishnu Priya, Aseem Setia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113451-113451
Open Access | Times Cited: 22
Susanta Kumar Rout, Vishnu Priya, Aseem Setia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113451-113451
Open Access | Times Cited: 22
Smart Delivery Vehicles for Cancer: Categories, Unique Roles and Therapeutic Strategies
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4
Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma
Binfeng Liu, Chenbei Li, Shasha He, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114545-114545
Closed Access
Binfeng Liu, Chenbei Li, Shasha He, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114545-114545
Closed Access
PIGR predicts good clinical outcomes and plays a tumor suppressor role in the development of breast cancer
Tengfei Jiang, Zhi Sun, Ke Dong, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tengfei Jiang, Zhi Sun, Ke Dong, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Supercritical fluid technology: A game-changer for biomacromolecular nanomedicine preparation and biomedical application
Yating Zheng, Yulan Huang, Jing Luo, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109169-109169
Closed Access | Times Cited: 10
Yating Zheng, Yulan Huang, Jing Luo, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109169-109169
Closed Access | Times Cited: 10
Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy
Lamei Guo, Jinjun Yang, Hao Wang, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7750-7750
Open Access | Times Cited: 9
Lamei Guo, Jinjun Yang, Hao Wang, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7750-7750
Open Access | Times Cited: 9
Red and near-infrared light-activated photoelectrochemical nanobiosensors for biomedical target detection
Yeison Monsalve, Andrés F. Cruz‐Pacheco, Jahir Orozco
Microchimica Acta (2024) Vol. 191, Iss. 9
Open Access | Times Cited: 3
Yeison Monsalve, Andrés F. Cruz‐Pacheco, Jahir Orozco
Microchimica Acta (2024) Vol. 191, Iss. 9
Open Access | Times Cited: 3
Transformable vesicles for cancer immunotherapy
Shuang Wang, Xiaoming Hu, Wei Wei, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113905-113905
Closed Access | Times Cited: 23
Shuang Wang, Xiaoming Hu, Wei Wei, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113905-113905
Closed Access | Times Cited: 23
Temperature-Responsive Nanocarrier-Regulated Alternative Release of “Cargos” for a Multiplex Photoelectrochemical Bioassay of Antibiotic-Resistant Genes
Lijuan Liu, Xin Li, Qingfeng Yao, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 40, pp. 14061-14070
Closed Access | Times Cited: 14
Lijuan Liu, Xin Li, Qingfeng Yao, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 40, pp. 14061-14070
Closed Access | Times Cited: 14
Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
Marzia Conte, Valentina Cauda
Advanced Therapeutics (2022) Vol. 5, Iss. 11
Open Access | Times Cited: 13
Marzia Conte, Valentina Cauda
Advanced Therapeutics (2022) Vol. 5, Iss. 11
Open Access | Times Cited: 13
Tumor Cell‐Responsive Photodynamic Immunoagent for Immunogenicity‐Enhanced Orthotopic and Remote Tumor Therapy
Yingchao Chen, Tao Xiong, Xueze Zhao, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 5
Closed Access | Times Cited: 13
Yingchao Chen, Tao Xiong, Xueze Zhao, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 5
Closed Access | Times Cited: 13
Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles
Soraia Fernandes, Marco Cassani, Francesca Cavalieri, et al.
Advanced Science (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 6
Soraia Fernandes, Marco Cassani, Francesca Cavalieri, et al.
Advanced Science (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 6
Effects of Low Molecular Weight Peptides from Red Shrimp (Solenocera crassicornis) Head on Immune Response in Immunosuppressed Mice
Rui Zhao, Shuoqi Jiang, Yunping Tang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10297-10297
Open Access | Times Cited: 4
Rui Zhao, Shuoqi Jiang, Yunping Tang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10297-10297
Open Access | Times Cited: 4
Multi-Armed Anti-CD40-Mediated Dual Drug Delivery System Based on Mesoporous Silica/Au Nanorod Nanocomposites for Multimodality Imaging and Combination Therapy
H. T. Feng, Yangjing Zhao, Yeping Li, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 14, pp. 13001-13012
Closed Access | Times Cited: 4
H. T. Feng, Yangjing Zhao, Yeping Li, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 14, pp. 13001-13012
Closed Access | Times Cited: 4